Eric Easom - 31 Dec 2024 SCHEDULE 13G/A Report for AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX)

Filing Manager: Eric Easom
Reporting Manager: Eric Easom
Security: AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol: ANTX
Shares outstanding: 30,534,387 shares
Disclosed Ownership: 1,893,132 shares
Ownership: 6.2%
Form type: SCHEDULE 13G/A
Filing time: 13 Feb 2025, 16:30:03 UTC
Date of event: 31 Dec 2024
Next filing: 13 Feb 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Eric Easom	6.2%	1,893,132	1,893,132	0	/s/ Eric Easom	Eric Easom